FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1698-1700 December 3, 1998 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Cassileth, P. A. PubMed Citation

In patients under the age of 60 who have acute myeloid leukemia, chemotherapy now routinely produces a complete remission in 70 to 80 percent of cases.^1,2 Since it is generally accepted that survival is poor if relapse occurs, the priority is to make the most of the remission. Patients in this age group have three options after they enter remission.

If an HLA-matched sibling donor is available, allogeneic hematopoietic stem-cell transplantation is usually chosen. This strategy offers a 50 to 60 percent chance of cure; it became standard treatment in the early 1980s, when the five-year survival with chemotherapy was . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Jabbour, E. J., Estey, E., Kantarjian, H. M. (2006). Adult Acute Myeloid Leukemia. Mayo Clin Proc. 81: 247-260 [Abstract] [Full Text]  
• Woods, W. G., Neudorf, S., Gold, S., Sanders, J., Buckley, J. D., Barnard, D. R., Dusenbery, K., DeSwarte, J., Arthur, D. C., Lange, B. J., Kobrinsky, N. L. (2001). A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group. Blood 97: 56-62 [Abstract] [Full Text]  
• Harousseau, J. L., Witz, B., Lioure, B., Hunault-Berger, M., Desablens, B., Delain, M., Guilhot, F., Le Prise, P. Y., Abgrall, J. F., Deconinck, E., Guyotat, D., Vilque, J. P., Casassus, P., Tournilhac, O., Audhuy, B., Solary, E. (2000). Granulocyte Colony-Stimulating Factor After Intensive Consolidation Chemotherapy in Acute Myeloid Leukemia: Results of a Randomized Trial of the Groupe Ouest-Est Leucemies Aigues Myeloblastiques. JCO 18: 780-780 [Abstract] [Full Text]  
• Kanda, Y., Miwa, A., Togawa, A., Perez-Calvo, J., Brugarolas, A., Suzuki, R., Seto, M., Morishima, Y., Gorin, N.-C., Labopin, M., Woods, W. G., Sanders, J. E., Neudorf, S., Cassileth, P. A., Appelbaum, F. R., Wiernik, P. H., Burnett, A. K. (1999). Treatment of Acute Myeloid Leukemia. NEJM 340: 1436-1439 [Full Text]